Capital Flow Monitor · Sponsors · CIK 1788028
Jasper Therapeutics, Inc.
2200 BRIDGE PKWY, REDWOOD CITY, CA, 94065 · 650-549-1400
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$132.0M
Sold
$132.0M
% sold
100.0%
Investors
40
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-05 | D ·current | 506(b) | $132.0M | $132.0M | 100.0% | 40 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Herb Cross — Executive Officer, Redwood City, CA
- Jeet Mahal — Executive Officer / Director, Redwood City, CA
- Patrick Crutcher — Director, Redwood City, CA
- Thomas Wiggans — Director, Redwood City, CA
- Judith Shizuru — Director, Redwood City, CA
- Svetlana Lucas — Director, Redwood City, CA
-
Kurt von Emster — Director, Redwood City, CA
1 other raise
- Iambic Therapeutics, Inc. $99.3M of $125.0M · 79.4%
- Wenru Song — Executive Officer, Redwood City, CA
- Gregory F. Keenan — Executive Officer, Redwood City, CA
- Matthew E. Ros — Director, Redwood City, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.